Document 3258 DOCN M94A3258 TI Phenotypic heterogeneity between peripheral blood (PB) and lymph node (LN) HIV isolates. DT 9412 AU Tamalet C; Lafeuillade A; Vignoli C; Rousseau S; DeMicco P; Department of Virology, TimoneHospital, Marseille, France. SO Int Conf AIDS. 1994 Aug 7-12;10(1):117 (abstract no. PA0086). Unique Identifier : AIDSLINE ICA10/94369317 AB OBJECTIVE: Previous results obtained by PCR or coculture techniques have shown higher viral burden in lymph node mononuclear cells (LNMCs) than in peripheral blood mononuclear cells(PBMCs). The aim of this study was to comparate the phenotype of HIV simultaneously isolated from PB and LN in HIV infected patients (pts). METHODS: Patients :11 HIV-1 and 1 HIV-2 infected adult pts(CDC I: 1, CDC III: 8, CDCIVC2: 3). 9 untreated pts, 3 on Zidovudine (ZDV) or ddI therapy. Cells:PBMCs and LNMCs from LN surgically excised for diagnostic purposes were obtained on the same day. Virological studies: PB and LNMC load:ANRS consensus coculture protocols performed on fresh samples. In vitro sensitivity to ZDV: cell-free isolate sensitivity assay (ANRS consensus technique). SI phenotype of isolates assayed on PBMCs and MT-2 cells. RESULTS: Frequency of infected cells was one log greater in LNMCs compared to PBMCs in the 12 pts investigated. PBMC and LN isolates recovered from the 9 ZDV naive pts were sensitive to ZDV with similar IC50 and IC90 values. PBMC and LN isolates from 2 pts were ZDV sensitive after at least 12 months of ZDV therapy. LN isolate from one IVC2 pt who had switched one year before to ddI after 12 months of ZDV therapy, showed a five-fold increase in IC90 values contrasting with an IC50 of ZDV sensitive isolate. SI phenotype was found in LN isolates from 2 CDCIVC2 pts and 1 CDC III pt, while 9 LN isolates and all the 12 PBMC isolates were NSI. CONCLUSION: The presence in the only lymph nodes of isolates showing either reduced sensitivity to ZDV or SI phenotype suggests a greater heterogeneity of LN isolates compared to PBMC isolates and these data could contribute to our understanding of pathogenesis of HIV infection. DE Adult Comparative Study Didanosine/THERAPEUTIC USE Drug Resistance, Microbial Human HIV Infections/DRUG THERAPY/ETIOLOGY/*MICROBIOLOGY HIV-1/DRUG EFFECTS/GENETICS/*ISOLATION & PURIF HIV-2/DRUG EFFECTS/GENETICS/*ISOLATION & PURIF In Vitro Leukocytes, Mononuclear/*MICROBIOLOGY Lymph Nodes/*MICROBIOLOGY Microbial Sensitivity Tests Phenotype Zidovudine/THERAPEUTIC USE MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).